SCHEMBL20184989

SCHEMBL20184989

CCNC(=O)c1[nH]cnc1C(=O)NC1CCC2(CC1)CCN(c1ccc(F)cc1Cl)C2=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.40
CRHR1 P34998 3/20 0.39
CRHR2 Q13324 1/20 0.39
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
ALDH1A1 P00352 1/20 0.38
IP6K1 Q92551 2/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP2D6 P10635 1/20 0.35
PKM P14618 1/20 0.35
CYP2C19 P33261 1/20 0.35
MAPT P10636 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
DYRK1A Q13627 1/20 0.34
P2RX7 Q99572 3/20 0.34
OPRL1 P41146 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18208204 1.00 L3MBTL1 (0.40) L3MBTL1CRHR1CRHR2CNR1CNR2
SCHEMBL18216524 0.97 CRHR1 (0.39) L3MBTL1CRHR1CRHR2CNR1CNR2
SCHEMBL18216270 0.92 HPGD (0.41) L3MBTL1CRHR1CRHR2ALDH1A1HPGD
SCHEMBL20184995 0.92 HPGD (0.41) L3MBTL1CRHR1CRHR2ALDH1A1HPGD
SCHEMBL20205205 0.92 HPGD (0.41) L3MBTL1CRHR1CRHR2ALDH1A1HPGD
SCHEMBL20184954 0.91 KMT2A (0.43) L3MBTL1CRHR1CRHR2CNR1CNR2
SCHEMBL18208486 0.91 KMT2A (0.43) L3MBTL1CRHR1CRHR2CNR1CNR2
SCHEMBL18208662 0.91 L3MBTL1 (0.39) L3MBTL1CRHR1CRHR2CNR1CNR2
SCHEMBL20184972 0.91 L3MBTL1 (0.39) L3MBTL1CRHR1CRHR2CNR1CNR2
SCHEMBL20205113 0.90 KMT2A (0.41) L3MBTL1CRHR1CRHR2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES C1R, C9, C1S L3MBTL1 2341/4885CRHR1 1606/4885CRHR2 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.